Suppr超能文献

相似文献

3
Techniques for antifungal susceptibility testing of Candida albicans biofilms.
Methods Mol Med. 2005;118:71-9. doi: 10.1385/1-59259-943-5:071.
4
Characteristics of biofilm formation by Candida albicans.
Rev Iberoam Micol. 2001 Dec;18(4):163-70.
5
Role for cell density in antifungal drug resistance in Candida albicans biofilms.
Antimicrob Agents Chemother. 2007 Jul;51(7):2454-63. doi: 10.1128/AAC.01237-06. Epub 2007 May 14.
6
Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.
Antimicrob Agents Chemother. 2001 Sep;45(9):2475-9. doi: 10.1128/AAC.45.9.2475-2479.2001.
7
Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
Antimicrob Agents Chemother. 2008 Sep;52(9):3259-66. doi: 10.1128/AAC.00541-08. Epub 2008 Jul 14.
9
Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents.
Med Mycol. 2010 Mar;48(2):421-6. doi: 10.1080/13693780903136879.
10
A Simple 96-Well Plate-Based Method for Development of Candida Biofilms Under Static Conditions.
Methods Mol Biol. 2022;2542:225-231. doi: 10.1007/978-1-0716-2549-1_16.

引用本文的文献

2
Antibacterial, antifungal, and antibiofilm activities of biogenic zinc nanoparticles against pathogenic microorganisms.
Front Cell Infect Microbiol. 2025 Jul 14;15:1545119. doi: 10.3389/fcimb.2025.1545119. eCollection 2025.
3
Spatial structure of yeast biofilms and the role of cell adhesion across different media.
Biofilm. 2025 Jul 14;10:100306. doi: 10.1016/j.bioflm.2025.100306. eCollection 2025 Dec.
4
Fungal Biofilm: An Overview of the Latest Nano-Strategies.
Antibiotics (Basel). 2025 Jul 17;14(7):718. doi: 10.3390/antibiotics14070718.
6
Trichophyton rubrum inhibits Candida albicans filamentation and its gene expression when grown in biofilms in vitro.
Mem Inst Oswaldo Cruz. 2025 Jun 27;120:e240221. doi: 10.1590/0074-02760240221. eCollection 2025.
8
V and ζ-potential of Candida albicans corelate with biofilm formation.
Sci Rep. 2025 Jul 2;15(1):22475. doi: 10.1038/s41598-025-06371-5.
9
A spatial transcriptomic atlas of the host response to oropharyngeal candidiasis.
mBio. 2025 Aug 13;16(8):e0084925. doi: 10.1128/mbio.00849-25. Epub 2025 Jun 30.
10
Monitoring of biofilm inhibition by using real-time impedance-based technology.
Curr Med Mycol. 2024 Nov 16;10. doi: 10.22034/cmm.2024.345240.1541. eCollection 2024.

本文引用的文献

3
Nosocomial fungal infections: epidemiology, diagnosis, and treatment.
Med Mycol. 2007 Jun;45(4):321-46. doi: 10.1080/13693780701218689.
4
A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents.
FEMS Microbiol Lett. 2007 Jul;272(2):172-81. doi: 10.1111/j.1574-6968.2007.00745.x. Epub 2007 May 8.
5
Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance.
J Med Microbiol. 2006 Aug;55(Pt 8):999-1008. doi: 10.1099/jmm.0.46569-0.
6
Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device.
APMIS. 2006 Apr;114(4):298-306. doi: 10.1111/j.1600-0463.2006.apm_394.x.
7
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Antimicrob Agents Chemother. 2006 Mar;50(3):1021-33. doi: 10.1128/AAC.50.3.1021-1033.2006.
8
Non-glucan attached proteins of Candida albicans biofilm formed on various surfaces.
Mycopathologia. 2006 Jan;161(1):3-10. doi: 10.1007/s11046-005-0167-2.
9
Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p.
Curr Biol. 2005 Jun 21;15(12):1150-5. doi: 10.1016/j.cub.2005.05.047.
10
Comparison of three assays for the quantification of Candida biomass in suspension and CDC reactor grown biofilms.
J Microbiol Methods. 2005 Dec;63(3):287-95. doi: 10.1016/j.mimet.2005.03.014. Epub 2005 Jun 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验